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Caveolar endocytosisWe investigated themechanism bywhich equine herpesvirus-1 (EHV-1) enters primary cultured equine brain
microvascular endothelial cells (EBMECs) and equine dermis (E. Derm) cells. EHV-1 colocalized with caveolin
in EBMECs and the infection was greatly reduced by the expression of a dominant negative form of equine
caveolin-1 (ecavY14F), suggesting that EHV-1 enters EBMECs via caveolar endocytosis. EHV-1 entry into E.
Derm cells was signiﬁcantly reduced by ATP depletion and treatments with lysosomotropic agents. Enveloped
virions were detected from E. Derm cells by infectious virus recovery assay after viral internalization,
suggesting that EHV-1 enters E. Derm cells via energy- and pH-dependent endocytosis. These results suggest
that EHV-1 utilizes multiple endocytic pathways in different cell types to establish productive infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Viruses deliver their genomes and accessory proteins into host
cells in order to initiate their replication. Certain enveloped viruses,
including retroviruses (Stein et al., 1987), enter cells through direct
fusion of the virion envelope with the plasma membrane, a process
that is followed by the release of the viral capsid or genome into the
cytoplasm. Other enveloped viruses, such as inﬂuenza virus (Matlin et
al., 1981) and Semliki Forest virus (Helenius et al., 1980), as well as
most nonenveloped viruses rely on the cellular endocytic machinery
for their entry into host cells.
Productive infection with alphaherpesviruses had been thought to
be established only by direct fusion of the viral envelope with the
plasma membrane, as demonstrated by electron microscopic analysis
and the effects of treatment with neutralizing antibodies (Fuller and
Spear, 1987; Fuller et al., 1989; Fuller and Lee, 1992). Agents that
perturb endocytosis were found to have little or no effect on herpes
simplex virus (HSV) infection in HEp-2 and Vero cells (Wittels and
Spear, 1991). Furthermore, entry of HSV-1 via endocytic vesicles was
shown to result in degradation of the virus particles (Campadelli-
Fiume et al., 1988). However, it has recently become clear that HSV
successfully infects HeLa, receptor-expressing CHO, and C10 murine. Hasebe),
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ll rights reserved.melanoma cells as well as primary and transformed human epidermal
keratinocytes via endocytosis (Nicola et al., 2003, 2005; Nicola and
Straus, 2004; Milne et al., 2005). The cellular and viral requirements
for the endocytic entry of HSV into these cells have been character-
ized. In HeLa and receptor-expressing CHO cells, infectious entry of
HSV requires trafﬁcking of the virus to an acidic intracellular
compartment, phosphatidylinositol 3-kinase activity, glycoprotein D
(gD) receptors, as well as viral gB, gD, and gH–gL (Nicola et al., 2003;
Nicola and Straus, 2004). The pathway into C10 murine melanoma
cells is gD receptor dependent but independent of vesicles with a low
pH (Milne et al., 2005). HSV enters primary and transformed human
epidermal keratinocytes, an important target cell population in vivo,
by a pH- and tyrosine phosphorylation-dependent mechanism
(Nicola et al., 2005).
Equine herpesvirus-1 (EHV-1), an alphaherpesvirus of the family
Herpesviridae, is distributed worldwide and causes rhinopneumoni-
tis, abortion, and encephalomyelitis in horses (Storts and Montgom-
ery, 2001). With the use of ultrastructural analysis, we have
previously suggested that EHV-1 enters equine brain microvascular
endothelial cells (EBMECs) via endocytosis (Hasebe et al., 2006).
Similar ultrastructural observations were described for EHV-1
endocytosis in mouse ﬁbroblast L-M cells (Abodeely et al., 1970).
Frampton et al. (2007) demonstrated that EHV-1 strain L11ΔgIΔgE,
which lacks gI and gE, enters CHO-K1 cells by endocytosis, while entry
pathway into equine dermis (E. Derm) cells and rabbit kidney (RK13)
cells is direct fusion of viral envelope with the plasma membrane. van
deWalle et al. (2008) reported that integrin on the surface of the host
cells is involved in the endocytosis of EHV-1. It has remained unclear,
Fig. 2. Ultrastructural analysis of EHV-1 entry into EBMECs (A) and E. Derm cells (B,
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enter the susceptible cells.
Here, we have investigated the entry mechanism of EHV-1 into
EBMECs and E. Derm cells. With the use of confocal immunoﬂuores-
cence microscopy, we examined the localization both of EHV-1 and of
the endocytic markers clathrin and caveolin during viral internaliza-
tion. Moreover, we evaluated the involvement of caveolar endocytosis
in EHV-1 entry with the cells expressing a dominant negative form of
caveolin-1. We also assessed the role of tyrosine kinase activity and of
low pH in the endosomal compartment in EHV-1 entry with the use of
pharmacological approaches. We also performed energy depletion
experiments and infectious virus recovery assay for direct indications
of endocytosis. Our data identify caveolar endocytosis as an entry
pathway for alphaherpesviruses. Moreover, our results demonstrate
the existence of multiple endocytic pathways for EHV-1 entry.
Results
Susceptibility of EBMECs and E. Derm cells to EHV-1 infection
EBMECs and E. Derm cells were examined for their ability to
support EHV-1 replication. Kinetics of viral growth in E. Derm cells
was similar to those in EBMECs (Fig. 1), which were typical of a fully
productive infection (Hasebe et al., 2006). These results demonstrated
that both EBMECs and E. Derm cells were susceptible to EHV-1
infection and that there was no signiﬁcant difference in viral
replication between EBMECs and E. Derm cells.
Ultrastructural analysis of the early stage of EHV-1 entry
We have previously suggested that the entry of EHV-1 in EBMECs
occurs via endocytosis by using electron microscopy (Hasebe et al.,
2006).Here,we further examined themodeof EHV-1 entry into EBMECs
and E. Derm cells using electronmicroscopy. At 10min post infection
(p.i.), enveloped virions were detected in noncoated vesicles within
the cytoplasm of EBMECs (Fig. 2A, Hasebe et al., 2006) and E. Derm cells
(Figs. 2B, C). These observations imply that EHV-1enters E.Dermcells as
well as EBMECs via endocytosis. We were unable to quantify the
numbers of enveloped viral particles in the endosomes, because we
could not catch enough particles having the complete recognizable
structure (i.e. core, capsid and envelope) for the quantiﬁcation.
Localization of EHV-1 and clathrin during viral internalization
Clathrin-dependent endocytosis plays a major role in the entry of
many viruses, having been classically described for Semliki ForestFig. 1. Viral growth in EBMECs (solid circles) and E. Derm cells (open squares) infected
at an m.o.i. of 5 p.f.u. per cell. Each point represents the amount of cell-associated virus
as the mean of three determinations. The error bars indicate the SD. The results are
representative of 2 independent experiments.
C). Cells were incubated with EHV-1 at an m.o.i. of 150 p.f.u. per cell ﬁrst for 2 h at
4 °C and then for 10 min at 37 °C. Scale bars represent 200 nm. PM, plasma
membrane. N, nucleus.virus, vesicular stomatitis virus, and inﬂuenza virus (Helenius et al.,
1980; Matlin et al., 1981, 1982). Although the vesicles containing the
virions appeared not to possess clathrin coats by electron microscopy
(Fig. 2; Hasebe et al., 2006), these observations did not exclude the
possible involvement of clathrin-dependent endocytosis in EHV-1
entry. We therefore examined the EHV-1-infected cells by two-color
immunoﬂuorescence staining for EHV-1 and clathrin-heavy chain at
10 or 30 min p.i. Both in infected EBMECs (Figs. 3A–F) and E. Derm
cells (Figs. 3G–L), EHV-1 immunoreactivity did not colocalize with
clathrin at any time points. Lack of cross reactivity of anti-EHV-1
antibodies with anti-clathrin antibody was conﬁrmed by the double
staining of uninfected EBMECs and E. Derm cells (data not shown).
The speciﬁcity of the mouse monoclonal antibody to clathrin-heavy
chain in EBMECs and E. Derm cells was examined byWestern blotting,
in which the antibody detected the speciﬁc band at 180 kDa (data not
shown).
Fig. 3. Distribution of EHV-1 immunoreactivity and clathrin during viral entry. EBMECs (A–F) and E. Derm cells (G–L) were infected with EHV-1 at an m.o.i. of 10 p.f.u. per cell for 10
(A–C, G–I) or 30 min (D–F, J–L) at 37 °C, ﬁxed, and processed for double immunoﬂuorescence staining of EHV-1 (green) and clathrin-heavy chain (red). Scale bars represent 5 μm.
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Caveolar endocytosis has emerged as a route of entry for several
viruses including simian virus 40 (SV40) (Anderson et al., 1996),
mouse polyomavirus (Richterová et al., 2001; Gilbert et al., 2003;
Gilbert and Benjamin, 2004), echovirus (Marjomäki et al., 2002),
human papillomavirus type 31 (Bousarghin et al., 2003; Smith et al.,
2007), human polyomavirus BK (BKV) (Eash et al., 2004), and species
C human adenovirus (Colin et al., 2005). So we next examined the
possible association of caveolae with EHV-1 during viral internaliza-
tion. Two-color immunostaining revealed that EHV-1 gB and caveolin,the major component of caveolae, were colocalized in EBMECs at 10
(Figs. 4A–C) and 30 min p.i. (Figs. 4D–F). Three ﬁelds were chosen at
random and more than 50 signals for EHV-1 immunoreactivity were
counted. Approximately 40% of the EHV-1 signal in EBMECs was
colocalized with caveolin at 10 min p.i. The percentage of colocaliza-
tion was reduced to 19% at 30 min p.i. Such colocalization was not
detected in infected E. Derm cells at any time points (Figs. 4G–L). Lack
of cross reactivity of anti-EHV-1 antibody with anti-caveolin anti-
bodies was conﬁrmed by the double staining of uninfected EBMECs
and E. Derm cells (data not shown). The speciﬁcity of the rabbit
polyclonal antibodies to caveolin in EBMECs and E. Derm cells was
Fig. 4. Distribution of EHV-1 gB and caveolin during viral entry. EBMECs (A–F) and E. Derm cells (G–L) were infected with EHV-1 at an m.o.i. of 10 p.f.u. per cell for 10 (A–C, G–I) or
30 min (D–F, J–L) at 37 °C, ﬁxed, and processed for double immunoﬂuorescence staining of EHV-1 gB (green) and caveolin (red). Arrowheads show colocalization of EHV-1 gB and
caveolin. Scale bars represent 5 μm.
201R. Hasebe et al. / Virology 393 (2009) 198–209examined by Western blotting, in which the antibodies detected the
speciﬁc bands at 24 kDa for alpha isoform and/or 21 kDa for beta
isoform (data not shown).
Effects of a dominant negative form of caveolin-1 in EHV-1 entry
Previous studies have reported that the tyrosine phosphorylation
of caveolin-1 at residue 14 mediates the release of caveolae from the
plasma membrane and is an integral part of certain signaling
pathways (Parton et al., 1994; Aoki et al., 1999; Orlichenko et al.,
2006). To conﬁrm the involvement of caveolae vesicles in EHV-1 entryinto EBMECs, we constructed equine caveolin-1 mutant. This mutant
encodes a protein in which tyrosine 14 is mutated to phenylalanine
(ecavY14F). This mutant has been known to act as a dominant
negative inhibitor of caveolin-1 (Orlichenko et al., 2006). The
ecavY14F construct and wild type equine caveolin-1 (WT ecav)
were expressed in EBMECs and E. Derm cells using a lentivirus vector.
Cells expressing either WT ecav or ecavY14F were infected with EHV-
1 strain Ab4-GFP (Ab4-GFP). The Ab4-GFP harbors a GFP expression
cassette between gene 62 and gene 63 (Ibrahim et al., 2004).
Therefore, the viral infected cells show GFP signal. Fewer EHV-1-
infected EBMECs were observed in cells expressing ecavY14F than in
202 R. Hasebe et al. / Virology 393 (2009) 198–209cells expressing WT ecav (p b0.01). However, there was no difference
in the number of the EHV-1-infected E. Derm cells expressing
ecavY14F or WT ecav (Figs. 5A, B). Expression of WT ecav and
ecavY14F was conﬁrmed by Western blotting with rabbit anti-
caveolin polyclonal antibodies (Fig. 5C).Effects of a tyrosine kinase inhibitor on EHV-1 entry
The effects of endocytosis inhibitors on EHV-1 infection were
assessed by quantiﬁcation of ICP0 RNA, the product of an early gene of
EHV-1. The production of ICP0 RNA is indicative of successful entry of
the viral genome into the nucleus and is maximal at 3 h p.i. in RK13
cells (Kimura et al., 2004). Given that the onset of EHV-1 DNA
synthesis in RK13 and L-M cells was detected at 4 h p.i. (Caughman et
al., 1985; O'Callaghan et al., 1968), the abundance of ICP0 RNA at 3 h p.i.
is thought to reﬂect the number of virions that have infected the cells.
The ICP0 RNA could be detected in EHV-1-infected RK13 cells at a
multiplicity of infection (m.o.i.) of 0.004 plaque forming unit (p.f.u.) per
cell (data not shown).Fig. 5. Effects of the expression of a dominant negative form of equine caveolin-1 on EHV-1 in
1 per cell for 16 h p.i. (A) The GFP signals in the infected cells were detected by ﬂuorescent
cells expressing eitherWT ecav or ecavY14F determined as described inMaterials andmetho
versus the control value (Student's t test). The results are representative of 2 independen
ecavY14F (Y14F) with rabbit polyclonal antibodies to caveolin. Mock indicates the endogenPrevious studies have suggested that cellular tyrosine kinase
activity aids EHV-1 infection (Frampton et al., 2007). Cellular tyrosine
kinase activity is important for receptor-mediated endocytosis
(Greenberg et al., 1993; Lamaze et al., 1993; McPherson et al.,
2001). Furthermore, tyrosine phosphorylation of caveolin-1 at residue
14 is important in signaling pathways mediating release of caveolae
from the plasma membrane since caveolar ﬁssion is decreased by
kinase inhibition (Parton et al., 1994; Aoki et al., 1999). We therefore
examined the effects of genistein, a tyrosine kinase inhibitor
(Akiyama et al., 1987), on the endocytosis of EHV-1. The amount of
ICP0 RNA in EBMECs at 3 h p.i. was greatly reduced by treatment with
genistein at a concentration of 50 μg/ml (Fig. 6A). In contrast,
genistein had no effect on the abundance of ICP0 RNA in E. Derm cells.
To eliminate the possibility that the results of E. Derm cells were due
to the inefﬁcient uptake of genistein, we assessed the effect of
genistein on the tyrosine phosphorylation of caveolin-1 in E. Derm
cells (Fig. 6B). Tyrosine phosphorylation of caveolin-1 at residue 14
was diminished by the treatment of genistein at 100 μg/ml,
suggesting that the concentration of genistein used in this study
was effective to down-regulate the tyrosine phosphorylation offection. Cells expressingWT ecav or ecavY14F were infected with Ab4-GFP at anm.o.i. of
microscopy. Scale bars represent 500 μm. (B) The relative proportion of EHV-1 infected
ds. The graphs show themean of three determinations. The error bars show SD. ⁎Pb0.01
t experiments. (C) Western blotting analysis of the expression of WT ecav (WT) and
ous expression of caveolin-1 in EBMECs and E. Derm cells.
Fig. 6. Role of tyrosine phosphorylation of caveolin in EHV-1 entry. (A) Effects of
genistein on EHV-1 entry into EBMECs and E. Derm cells. Cells were incubated with the
indicated concentrations of genistein for 1 h at 37 °C, infected with EHV-1 at an m.o.i. of
5 p.f.u. per cell for 1 h, and then incubated for an additional 2 h in the continued
presence of genistein. The amount of EHV-1 ICP0 RNAwas normalized by the amount of
GAPDH mRNA and then expressed as a percentage of the value for infected cells not
treated with genistein (control). ⁎Pb0.001 versus the corresponding control value
(Student's t test). ND, not determined. The graphs show the mean of three
determinations. The error bars show SD. The results are representative of 2 dependent
experiments. (B) Effects of genistein on tyrosine phosphorylation in E. Derm cells. Cells
were incubated with the indicated concentrations of genistein for 1 h at 37 °C, collected
in lysis buffer. The cell lysates were immunoprecipitated with rabbit polyclonal
antibodies to caveolin and the immunoprecipitates were subjected to Western blotting
with a speciﬁc antibody to phosphorylated caveolin-1 at residue 14 (pcavY14).
203R. Hasebe et al. / Virology 393 (2009) 198–209caveolin-1. Neither the morphology of both cell types nor the level of
expression of the cellular housekeeping gene for horse GAPDH was
affected by genistein in both cell types at 50 μg/ml and 100 μg/ml
(data not shown).
Effects of lysosomotropic agents on EHV-1 entry
Low pH in endosome is important for many viruses to enter the
host cells either via clathrin-dependent endocytosis or clathrin- and
caveolae-independent pathway (Helenius et al., 1982; Yoshimura and
Ohnishi, 1984; Blumenthal et al., 1987; Nicola et al., 2003).
Intracellular low pH is involved in BKV entry by caveolae-dependent
endocytosis (Eash et al., 2004) although SV40 infection by caveolar
endocytosis is pH independent (Ashok and Atwood, 2003). To
determine whether an acidic compartment is required for EHV-1
infectivity, we examined the effects of lysosomotropic agents on EHV-
1 ICP0 RNA production. Cells were treated with baﬁlomycin A1 and
ammonium chloride to neutralize the pH of acidic organelles (Tsiang
and Superti, 1984; van Weert et al., 1995; Dröse and Altendorf, 1997)
and infected with EHV-1 in the continued presence of the reagent. The
abundance of ICP0 RNA in E. Derm cells was reduced in a
concentration-dependent manner by treatment with baﬁlomycin A1
(Fig. 7A) and ammonium chloride (Fig. 7B). On the other hand, EHV-1
entry into EBMECs was not inhibited by baﬁlomycin A1 (Fig. 7A) and
ammonium chloride at 10 mM (Fig. 7B). The effect of ammonium
chloride at 20 mM in EBMECs was not determined, because the
expression of horse GAPDH was signiﬁcantly reduced (p b0.01; data
not shown) suggesting that 20 mM of ammonium chloride is toxic in
EBMECs. A ﬂuorescent pH indicator probe, LysoSensor™ Yellow/Blue
DND-160, was used to conﬁrm that the pH of the organelles was
neutralized. This probe exhibits a pH-dependent increase in ﬂuores-
cence intensity upon acidiﬁcation when the cells are excited at405 nm and the ﬂuorescence is emitted at 490 nm. Untreated EBMECs
and E. Derm cells exhibited punctuate staining. The staining of
LysoSensor was diminished in EBMECs by the treatment with 0.2 μM
of baﬁlomycin A1 and with 10 mM of ammonium chloride (Figs. 7C,
D). In E. Derm cells, signals of LysoSensor were diminished by the
treatment with 1 μM of baﬁlomycin A1 and 20 mM of ammonium
chloride (Figs. 7C, D). The concentration of baﬁlomycin A1 and
ammonium chloride used here seemed to be non-toxic, because
neither the morphology of both cell types nor the level of expression
of GAPDH was affected (data not shown).
Effects of ATP depletion on EHV-1 entry into E. Derm cells
EM studies and the effects of lysosomotropic agents suggest the
possibility that EHV-1 enters E. Derm cells via endocytosis. However,
these data are insufﬁcient to demonstrate that endocytosis is involved
in EHV-1 entry into E. Derm cells. To assess this possibility, we
examined the effect of ATP depletion on EHV-1 infection to E. Derm
cells. ATP depletion is known to inhibit endocytosis, but has no effect
on herpesvirus entry by direct fusion of viral envelopes with plasma
membranes (Nicola et al., 2003). E. Derm cells were pretreated with
glucose-free media containing 2-deoxy-D-glucose for 1 h, and then
infected with Ab4-GFP for 1 h in the continued presence of glucose-
free media. After virus infection, the media were replaced with
complete growth media. To conﬁrm that ATP depletion affects the
viral entry step, the cells were infected with EHV-1 with media
including glucose for 1 h, and then cultured with glucose-free media
for 2 h. The number of infected cells was later evaluated by counting
GFP-positive cells at 12 h p.i. ATP depletion during viral entry greatly
reduced EHV-1 infection (P b0.001) whereas ATP depletion post viral
entry did not signiﬁcantly reduce EHV-1 infection (Fig. 8).
Infectious virus recovery from E. Derm cells
Frampton et al. (2007) performed infectious virus recovery assays
to demonstrate that EHV-1 L11ΔgIΔgE strain enters CHO-K1 cells via
endocytosis. Since endocytosed virions possess envelopes in the early
phase of entry, infectivity can be detected by titration on RK13 cells.
On the other hand, when virus penetrates by direct fusion of envelope
with plasma membrane, infectious virions cannot be detected due to
the loss of the viral envelope. To conﬁrm that EHV-1 enters E. Derm
cells via endocytosis, we performed infectious virus recovery assay.
After incubation at 4 °C for 5 min, the cells were infected with EHV-1
at an m.o.i. of 10 p.f.u. per cell for 2 h at 4 °C. The temperature was
then shifted to 37 °C to allow the virus internalization. At 0, 7.5, 15, 30
and 45 min after the temperature shift, the viruses on the cell surface
were inactivated by washing with acidic buffer. The internalized
infectious viruses were titrated on RK13 cells. For a control to
eliminate the possibility of detecting virions remaining on the cell
surface, we used NIH3T3 cells, which seem to be resistant to EHV-1
entry because we could not detect viral RNA at 12 h p.i. by RT-PCR
(data not shown). At 0 and 7.5 min, no infectious virus was detected
from E. Derm and NIH3T3 cells. At 15min, virus was recovered from E.
Derm cells. The virus titer from E. Derm cells reached a peak at 30 min
and slightly declined at 45 min. In contrast, no virus was recovered
from NIH3T3 cells at any time point (Fig. 9).
Discussion
The colocalization of EHV-1 with caveolin at the early stage of
infection and the signiﬁcant effect of a dominant negative form of
caveolin-1 on the EHV-1 infection suggests that the virus enters
EBMECs via caveolar endocytosis. The results of double immunolabel-
ing indicated that clathrin-dependent endocytosis plays a relatively
minor role in EHV-1 entry into EBMECs. As far as we are aware, our
204 R. Hasebe et al. / Virology 393 (2009) 198–209study is the ﬁrst to demonstrate alphaherpesvirus entry into cells via
caveolar endocytosis.
The production of EHV-1 ICP0 RNA in EBMECs was blocked by the
tyrosine kinase inhibitor genistein, indicating a requirement fortyrosine phosphorylation in the entry of EHV-1 into these cells
although we cannot exclude the possibility that genistein might affect
ICP0 gene expression after viral entry. Tyrosine phosphorylation
initiates signal transduction events that lead to receptor-mediated
Fig. 8. Effect of ATP depletion on EHV-1 entry into E. Derm cells. The cells were treated
with ATP depletion media during (white bar) or post viral entry (black bar). For the
untreated control (gray bar), the cells were incubated in FBS-free media. The cells were
infected with Ab4-GFP at an m.o.i. of 5 per cell and EHV-1 infected cells were counted
by FACS. ⁎Pb0.001 versus the corresponding control value (Student's t test). The graphs
show the mean of three determinations. The error bars show SD. The results are
representative of 2 independent experiments.
Fig. 9. Infectious virus recovery assay. E. Derm (open square) and NIH3T3 cells (solid
circle) were infected with EHV-1 at an m.o.i. of 10 per cell at 4 °C for 2 h. Then the cells
were shifted to 37 °C to allow viral internalization. At the indicated times, the remaining
viruses on the cell surface were inactivated by acidic buffer. Internalized infectious
viruses were detected by titration on RK13 cells. The graphs show the mean of three
determinations. The error bars show SD.
205R. Hasebe et al. / Virology 393 (2009) 198–209endocytosis (McPherson et al., 2001). In caveolar endocytosis,
tyrosine kinase activity is required for phosphorylation of caveolin
at residue 14, which induces caveolar vesiculation and enclosure of
ligands within caveolae (Aoki et al., 1999; Chen and Norkin, 1999).
Our result indicated that EHV-1may induce caveolin phosphorylation,
which activates the subsequent signal transduction.
Caveolae have traditionally been described as smooth invagina-
tions of the plasma membrane with a diameter of 50 to 80 nm
(Palade, 1953; Yamada, 1955). Most viruses that have been shown
to enter host cells via caveolae are nonenveloped and therefore
smaller than typical caveolar invaginations. However, recent studies
have shown that this traditional description of caveolar morphology
is inadequate, as caveolae with ﬂat or tubular forms have also been
detected (Anderson, 1998). Caveolae-dependent endocytosis has
also been found to contribute to the entry of enveloped viruses,
such as ﬁloviruses and human coronavirus (Empig and Goldsmith,
2002; Nomura et al., 2004). Our data now provide support for the
notion that caveolar vesicles mediate the delivery of large
enveloped viruses.
Infection of endothelial cells in the horse central nervous system
(CNS) is required for establishment of EHV-1-induced encephalomy-
elitis, which is characterized by vasculitis, thrombosis, and secondary
ischemia of neuronal tissue (Edington et al., 1986). We have
previously proposed that EBMECs are an appropriate in vitro model
for studies of the endotheliotropism of EHV-1 (Hasebe et al., 2006).
Primary cultured brainmicrovascular endothelial cells (BMECs) retain
several characteristics of CNS endothelial cells in vivo (Joó, 1996).
Infection of human BMECs with Escherichia coli K1 results in the
formation of abundant caveolae that mediate bacterial uptake
(Sukumaran et al., 2002). Immunohistochemical studies of normal
brain tissue have also shown the caveolar compartment to be
pronounced in endothelial cells, suggesting an important physiolog-
ical role for caveolar mediated endocytosis in vivo (Virgintino et al.,
2002). It is therefore reasonable to propose that EHV-1 makes use of
caveolar endocytosis to infect endothelial cells in the horse CNS.
Viral entry through caveolae has traditionally been considered to
occur in a pH-neutral setting, bypassing the acidic endosome (AshokFig. 7. Role of a low pH in intracellular organelles in EHV-1 entry. (A) Effects of baﬁlomycin A1
concentrations of baﬁlomycin A1 for 1 h at 37 °C, infected with EHV-1 at an m.o.i. of 5 p.f.u. p
agent. The amount of EHV-1 ICP0 RNA was normalized by the amount of GAPDH mRNA and
(control). ⁎Pb0.01 versus the corresponding control value (Student's t test). The graphs
representative of 2 independent experiments. (B) Effects of ammonium chloride on EHV-1 e
ICP0 RNA with normalization by the amount of GAPDH mRNA. ⁎Pb0.01 versus the correspon
three determinations. The error bars show SD. The results are representative of 2 indepen
EBMECs and E. Derm cells. Cells were incubated with the indicated concentrations of baﬁlo
acidic organelles was evaluated by the ﬂuorescence intensity of LysoSensor Yellow/Blue DND
lysosomal pH in EBMECs and E. Derm cells with LysoSensor Yellow/Blue DND-160. Scale band Atwood, 2003). Recently, caveolin-1-positive endosomes have
been shown to deliver caveolae-internalized cargo to the Golgi
complex (Nichols, 2003) and BKV enters Vero cells via this pathway
(Eash et al., 2004). The effects of the lysosomotropic agent used in this
study suggest that acidic intracellular organelles do not facilitate EHV-
1 infection in EBMECs. Therefore, EHV-1 may be transported to pH-
neutral organelles after internalization via caveolae.
Immunoﬂuorescence microscopic analysis and the lack of an effect
of the dominant negative form of caveolin-1 on EHV-1 infection in E.
Derm cells suggested that EHV-1 entry occurred by a caveolae-
independent route. Such a route might be operative in vivo for EHV-1
infection of certain cell types, such as lymphocytes, that do not appear
to form caveolae. The principal pathway of EHV-1 entry into E. Derm
cells also appears to be clathrin independent, given that EHV-1
immunoreactivity did not colocalize with clathrin-heavy chain in
these cells.
Despite the lack of colocalization of EHV-1with endocyticmarkers,
our data from electron microscopy, lysosomotropic agent treatment,
energy depletions and infectious virus recovery assays suggest that
EHV-1 enters E. Derm cells via energy- andpH-dependent endocytosis.
In contrast, Frampton et al. (2007) suggested that EHV-1 strain
L11ΔgIΔgE entry into E. Derm cells occurs by direct fusion at the cell
surface. The difference between Frampton's study and our own could
be explained by the difference in virus strain. The strain L11ΔgIΔgE is a
mutantwhich lacks gI and gE, resulting in attenuated virulence inmice
and reduction of viral growth on RK13 cells compared to the parental
virus strain RacL11 (Frampton et al., 2002). It has been thought that gE
of varicella zoster virus (VZV), another Varicellovirus, is associated
with viral entry. Notably, Li et al. (2006) reported that gE interactswith
insulin-degrading enzyme, which acts as a cellular receptor mediating
cell-free VZV infection and cell-to-cell spread. Therefore, the lack of gE
might inﬂuence the EHV-1 entrymechanism. The dependence of entry
mechanisms on virus strain has been reported for human papilloma-
virus by Bousarghin et al. (2003), who demonstrated that althoughon EHV-1 entry into EBMECs and E. Derm cells. Cells were incubated with the indicated
er cell for 1 h, and then incubated for an additional 2 h in the continued presence of test
then expressed as a percentage of the value for infected cells not treated with reagent
show the mean of three determinations. The error bars show SD. The results are
ntry into EBMECs and E. Derm cells. Viral entry was evaluated by the amount of EHV-1
ding control value (Student's t test). ND, not determined. The graphs show the mean of
dent experiments. (C) Evaluation of the effects of baﬁlomycin A1 on lysosomal pH in
mycin A1 for 1 h at 37 °C and exposed to LysoSensor Yellow/Blue DND-160. The pH in
-160. Scale bars represent 10 μm. (D) Evaluation of the effects of ammonium chloride on
ars represent 10 μm.
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31 and 58 use different pathways to enter cells.
In conclusion, our results suggest that EHV-1 entry pathways are
cell type dependent. Furthermore, they show that EHV-1 enters
certain cell types via caveolar endocytosis, a pathway that has not
previously been known to mediate the entry of alphaherpesviruses.
Materials and methods
Cells and virus
The EBMECs were isolated from the brain of a 6-month-old horse
as described previously (Hasebe et al., 2006) and were cultured in
Medium 199 Earl's (Invitrogen, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS; Sigma, St. Louis, MO, USA) and both
penicillin (100 U/ml) and streptomycin (100 μg/ml) (Invitrogen). The
E. Derm cells were obtained from American Type Culture Collection
(Manassas, VA, USA) and cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 0.1 mM nonessential amino
acids (Invitrogen) and 10% FBS. The RK13 cells were cultured in
minimum essential medium (MEM) supplemented with 10% FBS. The
293T cells were cultured in DMEM supplemented with 10% FBS. The
EHV-1 strain HH1 was isolated from an aborted equine fetus in Japan
(Kawakami et al., 1970). An EHV-1 mutant, Ab4-GFP, was generously
provided by Dr. H. Fukushi. (Gifu University, Gifu, Japan). The Ab4-
GFP was constructed by inserting a GFP expression cassette into the
intergenic region between ORF62 and ORF63 of EHV-1 Ab4 strain
(Ibrahim et al., 2004). Stock viruses were grown in conﬂuent
monolayers of RK13 cells. In preparation for RNA dot-blot analysis,
viruses were treated with RNase (20 ng/ml) for 1 h at 37 °C to remove
contaminating RNA in the stock virus. Viral titer was determined by a
plaque formation assay using RK13 cells.
Chemicals and antibodies
Genistein was obtained from Sigma, and baﬁlomycin A1 and
ammonium chloride were from Wako (Osaka, Japan). Baﬁlomycin A1
and genistein were dissolved in dimethyl sulfoxide at 1 mM and
100 mg/ml, respectively. Ammonium chloride was dissolved in
distilled water at 5 M. The ﬁnal concentration of dimethyl sulfoxide
in culture medium was ≤0.1%, and the same concentration was also
added to control incubations.
Rabbit polyclonal antibodies to EHV-1 were kindly provided by Dr.
R. Kirisawa (Rakuno Gakuen University, Hokkaido, Japan), and a
mousemonoclonal antibody to EHV-1 gB protein was kindly provided
by Dr. T. Matsumura (Japan Racing Association, Tochigi, Japan). Rabbit
polyclonal antibodies to caveolin, a mouse monoclonal antibody to
caveolin (pY14) and a mouse monoclonal antibody to clathrin-heavy
chain were obtained from BD Transduction Laboratories (San Jose, CA,
USA). Alexa Fluor 488-conjugated goat antibodies to mouse immu-
noglobulin G, Alexa Fluor 594-conjugated goat antibodies to rabbit
immunoglobulin G, 4′,6-diamidino-2-phenylindole (DAPI) and Lyso-
Sensor™ Yellow/Blue DND-160 were from Molecular Probes (Leiden,
The Netherlands). Horse radish peroxidase (HRP)-conjugated goat
antibodies to mouse immunoglobulin and HRP-conjugated goat
antibodies to rabbit immunoglobulin were obtained from Biosource
(Camarillo, CA, USA).
Viral growth
Conﬂuent monolayers of EBMECs or E. Derm cells seeded into 24-
well plates were infected with EHV-1 at an m.o.i. of 5 p.f.u. per cell.
The infected cells were incubated at 37 °C for 1 h to allow attachment
of the virus, then washed three times with phosphate-buffered saline
(PBS), provided with fresh growth media, and incubated further at
37 °C. At 0 h (immediately after seeding the virus), 8 h, 16 h or 24 h p.i.,the supernatants were removed and the cells were collected. The cells
were suspended in 1 ml of MEM and lysed by three cycles of freezing
and thawing. Viral titer was determined by the plaque formation on
RK13 cells.
Electron microscopy
EBMECs or E. Derm cells cultured in six-well plates were exposed
to EHV-1 at an m.o.i. of 150 p.f.u. per cell and incubated for 2 h at 4 °C
to allow attachment of the virus to the cell surface. After subsequent
incubation for 10 min at 37 °C, the cells were collected and ﬁxed
overnight at 4 °C with 2.5% glutaraldehyde. The cells were
subsequently exposed to 2% osmic acid, dehydrated, and embedded
in Epon 812 (Shell Chemical Company, New York, NY, USA). Sections
were cut at a thickness of 70–80 nm,mounted on coated grids, stained
with uranyl acetate and lead citrate, and examined with an electron
microscope (JEM-1210; Japan Electron Optics Laboratory, Tokyo,
Japan).
Indirect immunoﬂuorescence staining
Conﬂuent monolayers of EBMECs or E. Derm cells in eight-well
chamber slides (BD Falcon, San Jose, CA, USA) were infected with
EHV-1 at an m.o.i. of 10 p.f.u. per cell. After incubation at 37 °C for 10
or 30 min, the cells were ﬁxed with 3.7% paraformaldehyde for 5 min
and permeabilized with 0.1% Triton X-100 for 5 min. The cells were
washedwith PBS and incubated for 1 h at room temperature ﬁrst with
2% bovine serum albumin (Sigma) and then with primary antibodies.
For simultaneous detection of EHV-1 and clathrin, cells were stained
with rabbit anti-EHV-1 polyclonal antibodies and mouse anti-
clathrin-heavy chain monoclonal antibody. For simultaneous detec-
tion of EHV-1 and caveolae, cells were stained withmouse anti-EHV-1
gB monoclonal antibody and rabbit anti-caveolin polyclonal anti-
bodies. Then the cells were incubated for 1 h at room temperature
with secondary antibodies, mounted with the use of ﬂuorescence
mounting medium (Dako Cytomation, Carpinteria, CA, USA), and
examined with a laser-scanning confocal microscope (Olympus,
Tokyo, Japan). For all primary antibodies, control images were
evaluated to ensure nonoverlapping binding of secondary antibodies
and speciﬁc detection for each excitation channel. The images were
processed with FV10-ASV 1.4 Viewer (Olympus). Coincidence of the
immunoreactivity between rabbit anti-EHV-1 polyclonal antibodies
and mouse anti-EHV-1 gB monoclonal antibody was conﬁrmed (data
not shown).
Preparation of lentiviral vector
The lentiviral vector systemwas provided by Dr. Hiroyuki Miyoshi,
RIKEN BioResource Center, Ibaraki, Japan. Full-length equine caveolin-
1 cDNA ampliﬁed by PCR from cDNA of EBMECs was cloned into
pcDNA 3.1(−) (Invitrogen) and CSII-CMV-MCS-IRES2-Bsd (RIKEN
BioResource Center). These constructs were designated as pcDNA 3.1
(−)-ecav and CSII-CMV-ecav-IRES2-Bsd, respectively. A mutant form
of equine caveolin-1was generated from pcDNA 3.1(−)-ecav via PCR-
based mutagenesis and subcloned into CSII-CMV-MCS-IRES2-Bsd,
which was designated as CSII-CMV-ecavY14F-IRES2-Bsd. Lentiviral
vectors pseudotyped with vesicular stomatitis virus G glycoprotein
(VSV-G) were generated according to the instruction provided by the
RIKEN BioResource Center. Brieﬂy, 293T cells were transfected with
the package construct (pCAG-HIVgp), the VSV-G-expressing construct
(pCMV-VSV-G-RSV-Rev) and the self-inactivating vector construct
(CSII-CMV-ecav-IRES2-Bsd or CSII-CMV-ecavY14F-IRES2-Bsd). After
48 h, the supernatant was concentrated by ultracentrifugation at
50,000 g for 2 h. The pellet was resuspended in Hanks' Balanced Salt
Solutions (Invitrogen). Vector titer was determined using HIV p24
ELISA Kit (PerkinElmer Life Sciences, Inc., Wellesley, MA, USA).
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The EBMECs and E. Derm cells were infected with lentiviral vectors
at anm.o.i. of 0.01 infectious unit per cell and incubated for 24 h. Then
the cells were infected with EHV-1 at an m.o.i. of 1 p.f.u. per cell. After
16 h, the cells were ﬁxed with 3.7% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and counterstained with DAPI, a nuclear stain.
The GFP and DAPI signal was evaluated with ﬂuorescent microscopy
(Olympus). The number of GFP expressing cells and the number of
nuclei were counted by Image-J (NIH, Bethesda, MD, USA). The
relative proportion of EHV-1-infected cells was calculated by dividing
the number of the GFP-positive cells by the number of the nuclei. The
number of the GFP-positive cells in wild type ecav expressing EBMECs
or E. Derm cells was deﬁned as 100%.
Expression of the transgene products was conﬁrmed by Western
blotting. The cells infected with lentiviral vector at 24 h p.i. were lysed
in RIPA buffer [10 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA,
50 mM NaF, 10% glycerol, 1% Triton X-100, 1% sodium deoxycholate,
0.1% SDS, 5 mM phenylmethylsulfonyl ﬂuoride], and mixed with
Complete protease inhibitor cocktail (Roche Diagnostics, Mannheim,
Germany). The cell lysates were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-page) and transferred to
PVDF membrane (Millipore, Billerica, MA, USA). The membrane was
blocked with 2% low-fat milk in Tris-buffered saline containing 0.05%
Tween 20 (TBS-T) at 4 °C overnight, incubated with a rabbit
polyclonal antibodies to caveolin (1:1,000 dilution in 2% low-fat
milk in TBS-T) for primary antibody, and then with HRP-conjugated
goat antibodies to rabbit immunoglobulin (1:5000 dilution in 2% low-
fat milk in TBS-T) for secondary antibody. The immunocomplex was
visualized with Immobilon™ western chemiluminescent HRP sub-
strate (Millipore) and LAS-1000mini (FUJIFILM, Tokyo, Japan).
Preparation of RNA probes
Complementary DNA fragments corresponding to EHV-1 ICP0 RNA
and horse glyceraldehydes-3-phosphate dehydrogenase (GAPDH)
were cloned by reverse transcription and PCR from total RNA
extracted either from EHV-1-infected RK13 cells or from uninfected
equine placenta, respectively, using PCR primers 5′-TTTTTGGCCGT-
GGATTCTGG-3′ and 5′-AGTTCTGCTTGGACGATGAG-3′ for ICP0 RNA
and 5′-AGTTCCATGGCACAGTCAAG-3′ and 5′-ACAAACATTGGGGCAT-
CAGC-3′ for GAPDH. The PCR products were cloned into the pGEM-T
vector (Promega, Madison, WI, USA), and the resultant plasmids were
sequenced to verify their identity.
Antisense RNA probes were prepared with a digoxigenin-based
RNA labeling kit (SP6/T7; Roche Diagnostics). Plasmids containing
cloned cDNA were linearized with Not I for synthesis of RNA in the
presence of digoxigenin-11-UTP. The labeled probes generated from
1 μg of plasmid DNAwere precipitated with ethanol, dissolved in 50 μl
of RNase-free water, and stored at −80 °C.
Dot-blot analysis
Conﬂuent monolayers of EBMECs or E. Derm cells in six-well plates
were treated with inhibitor at 37 °C for 1 h and then infected with
RNase-treated EHV-1 at an m.o.i. of 5 p.f.u. per cell for 1 h at 37 °C in
the continued presence of an inhibitor. After additional 2 h incubation
in the presence of inhibitor, total RNA was extracted with using Trizol
reagent (Invitrogen), treated with DNase with the use of a kit
(Ambion, Austin, TX, USA), and diluted to a concentration of 2 mg/ml.
Hybridization was performed as previously described (Kimura et al.,
2004). In brief, 1 μl of each sample was spotted onto a dry positively
charged nylon membrane (Roche) and allowed to dry in air. The RNA
was ﬁxed to the membrane with a UV cross-linker (XL-1000;
Spectronics, Lincoln, NE) and baked for 30 min at 80 °C. The
membranewas then incubated for 3 h at 68 °C in a solution containing0.25 M sodium phosphate buffer (pH 7.2), 10% SDS, 1 mM EDTA, and
2% blocking reagent. Hybridization was performed for 12 h at 68 °C in
the same solution containing the digoxigenin-labeled cRNA probe
(20 ng/ml), after which the membrane was washed three times (each
for 20 min) with 25 mM sodium phosphate buffer (pH 7.2) containing
10% SDS and 1 mM EDTA. Hybridization complexes were detected
with alkaline phosphatase-conjugated antibodies to digoxigenin and
disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2′-(5′-chloro)tricyclo
[3.3.1.1.3,7]decan}-4-yl) phenyl phosphate (CSPD) as the chemilumi-
nescent substrate (Roche). Quantitative analysis of autoradiograms
was performed with Scion Image software. The relative amount of
EHV-1 ICP0 RNA was calculated by dividing the intensity of the signal
for ICP0 RNA by that of the signal for GAPDH mRNA. The adjusted
signal intensity for infected but mock-treated cells was deﬁned as
100%.
Immunoprecipitation and Western blot analysis
Conﬂuent monolayers of E. Derm cells in 60 mm dishes were
treated with genistein at 37 °C for 1 h, washed once with PBS and
lysed in RIPA buffer with Complete protease inhibitor cocktail. The cell
lysates were mixed at 4 °C with rabbit polyclonal antibodies to
caveolin for 1 h and collected on protein A-Sepharose beads (GE
Healthcare Bio-Science Corp, NJ, USA). The immunoprecipitates were
subjected to SDS-page and Western blotting with a mouse monoclo-
nal antibody to caveolin (pY14) (1:1000 dilution in 2% low-fat milk in
TBS-T) or rabbit polyclonal antibodies to caveolin for primary
antibodies and HRP-conjugated goat antibodies to mouse immuno-
globulin (1:5000 dilution in 2% low-fat milk in TBS-T) or HRP-
conjugated goat antibodies to rabbit immunoglobulin for secondary
antibodies.
Vital staining with pH indicator
Cells seeded on 35mmglass bottom disheswere incubatedwith or
without baﬁlomycin A1 or ammonium chloride at 37 °C for 1 h, and
then exposed to 2 μM of a pH sensitive ﬂuorescence dye, LysoSensor
Yellow/Blue DND-160, in pre-warmed growth medium. After incu-
bation at 37 °C for 5 min, the medium was replaced with fresh
medium. The ﬂuorescence was observed using a confocal laser-
scanning microscope with excitation at 405 nm and emission was
measured at 480–510 nm.
ATP depletion
Cells were incubated in ATP depletionmedia composed of glucose-
free, FBS-free DMEM (Invitrogen) with 10 mM 2-deoxyglucose
(Sigma) for 1 h and infected with Ab4-GFP at an m.o.i. of 5 per cell
for 1 h in ATP depletion media. After EHV-1 infection, the cells were
treated with citrate buffer pH 3.0 to inactivate remaining viruses on
cell surface. The media were replaced with regular culture media and
the cells were cultured at 37 °C. For untreated controls, the cells were
incubated with FBS-free DMEM for 1 h, infected with Ab4-GFP in FBS-
free DMEM for 1 h and the media were replaced with regular culture
media. For samples depleted of ATP after post entry, the cells were
infected with Ab4-GFP in FBS-free DMEM. After viral infection for 1 h,
the cells were incubated in ATP depletionmedia for 2 h and the media
were replaced with regular culture media. At 12 h p.i., the cells were
harvested, ﬁxed with 4% paraformaldehyde and GFP-positive cells
were counted by FACS Canto (BD Biosciences, Sun Jose, CA, USA).
Infectious virus recovery assay
Infectious virus recovery assay was performed as previously
described in Frampton et al. (2007) with some modiﬁcations. E.
Derm and NIH3T3 cells seeded in 24 well plates were washed with
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incubated on ice for 5 min. The cells were infected with EHV-1 HH1
strain at an m.o.i. of 10 p.f.u. per cell for 2 h at 4 °C. The media were
replaced with pre-warmed fresh DMEM containing 25mMHEPES and
1% FBS at 37 °C. At 0, 7.5, 15, 30 and 45 min after incubation at 37 °C,
the cells were washed with glycine pH 3.0 for 1 min at room
temperature, washed with DMEM containing 25 mM HEPES and
harvested. The cells were freeze–thawed once and sonicated three
times for 15 s each. The infectious virus was detected by titration on
RK13 cells. Triplicate samples were measured for each time point.
Statistical analysis
Quantitative data are expressed as means±SD and were com-
pared with Student's t test. A P value of b0.05 was considered
statistically signiﬁcant.
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